Benedikte Hatz
Vorstandsvorsitzender bei TeGenero AG
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Erich Maximilian Platzer | M | 74 |
TeGenero AG
 TeGenero AG Pharmaceuticals: MajorHealth Technology TeGenero AG discovers and develops novel therapeutics. It is a biopharmaceutical company providing services in the identification and development of effective and applicable therapeutics for the treatment of severe immunological disorders. It's first development candidate TGN1412, a SuperMAB with specificity for the T cell surface receptor CD28 is in non-clinical development. Clinical applications of SuperMAB and its derived compounds are expected to solve unmet medical needs in the fields of cancer-related immunodeficiencies such as B-cell chronic lymphocytic leukaemia and autoimmune/inflammatory diseases like rheumatoid arthritis. The company was founded in 2000 and is headquartered in Wurzburg, Germany. | - |
| Patrick Baeuerle | M | 66 |
TeGenero AG
TeGenero AG Pharmaceuticals: MajorHealth Technology TeGenero AG discovers and develops novel therapeutics. It is a biopharmaceutical company providing services in the identification and development of effective and applicable therapeutics for the treatment of severe immunological disorders. It's first development candidate TGN1412, a SuperMAB with specificity for the T cell surface receptor CD28 is in non-clinical development. Clinical applications of SuperMAB and its derived compounds are expected to solve unmet medical needs in the fields of cancer-related immunodeficiencies such as B-cell chronic lymphocytic leukaemia and autoimmune/inflammatory diseases like rheumatoid arthritis. The company was founded in 2000 and is headquartered in Wurzburg, Germany. | - |
| Thomas Hanke | M | - |
TeGenero AG
TeGenero AG Pharmaceuticals: MajorHealth Technology TeGenero AG discovers and develops novel therapeutics. It is a biopharmaceutical company providing services in the identification and development of effective and applicable therapeutics for the treatment of severe immunological disorders. It's first development candidate TGN1412, a SuperMAB with specificity for the T cell surface receptor CD28 is in non-clinical development. Clinical applications of SuperMAB and its derived compounds are expected to solve unmet medical needs in the fields of cancer-related immunodeficiencies such as B-cell chronic lymphocytic leukaemia and autoimmune/inflammatory diseases like rheumatoid arthritis. The company was founded in 2000 and is headquartered in Wurzburg, Germany. | 24 Jahre |
| Doris Schmitt-Landsiedel | M | 71 |
Technische Universität München
| 28 Jahre |
| Thomas Huenig | M | - |
TeGenero AG
TeGenero AG Pharmaceuticals: MajorHealth Technology TeGenero AG discovers and develops novel therapeutics. It is a biopharmaceutical company providing services in the identification and development of effective and applicable therapeutics for the treatment of severe immunological disorders. It's first development candidate TGN1412, a SuperMAB with specificity for the T cell surface receptor CD28 is in non-clinical development. Clinical applications of SuperMAB and its derived compounds are expected to solve unmet medical needs in the fields of cancer-related immunodeficiencies such as B-cell chronic lymphocytic leukaemia and autoimmune/inflammatory diseases like rheumatoid arthritis. The company was founded in 2000 and is headquartered in Wurzburg, Germany. | 24 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Clemens Fischer | M | 49 |
Technische Universität München
| 6 Jahre |
| Peter Heinold | M | - |
Technische Universität München
| 5 Jahre |
| Andreas Schaller | M | - |
Technische Universität München
| 6 Jahre |
| Marion Weissenberger-Eibl | M | 57 |
Technische Universität München
| 6 Jahre |
| Moritz Friedrich Arne Hilf | M | - |
Technische Universität München
| 6 Jahre |
| Rainer Maerkle | M | 49 |
Technische Universität München
| 6 Jahre |
| Stefan Streng | M | 56 |
Technische Universität München
| 6 Jahre |
| Franz Josef Retzer | M | 51 |
Technische Universität München
| 4 Jahre |
| Klaus-Peter Estermaier | M | 54 |
Technische Universität München
| 4 Jahre |
| Emin Bulent Altan | M | 47 |
Technische Universität München
| 5 Jahre |
| Bernhard Müllinger | M | - |
Technische Universität München
| 4 Jahre |
| Michael Ruf | M | 60 |
Technische Universität München
| 3 Jahre |
| Jürgen Rebel | M | 52 |
Technische Universität München
| 3 Jahre |
| Thomas Deisboeck | M | - |
Technische Universität München
| 5 Jahre |
| Marc Hundsdorf | M | 56 |
Technische Universität München
| 5 Jahre |
| Martin Kaleja | M | 52 |
Technische Universität München
| 4 Jahre |
| Kristian Reich | M | 58 |
Technische Universität München
| 3 Jahre |
| Katerina Pistioli | F | 53 |
Technische Universität München
| 4 Jahre |
| Heiko von Dewitz | M | - |
Technische Universität München
| 6 Jahre |
| Erhardt Barth | M | - |
Technische Universität München
| 3 Jahre |
| Elisabetta Castiglioni | M | 59 |
Technische Universität München
| 4 Jahre |
| Arne Stoschek | M | - |
Technische Universität München
| 3 Jahre |
| Thomas Alt | M | - |
Technische Universität München
| 4 Jahre |
| Evangelos Pistiolis | M | 51 |
Technische Universität München
| 4 Jahre |
| Werner Lang | M | 56 |
Technische Universität München
| 3 Jahre |
| Ingo Rudolf Ederer | M | 56 |
Technische Universität München
| 3 Jahre |
| Richard Ammer | M | 54 |
Technische Universität München
| 3 Jahre |
| Berislav Gašo | M | 50 |
Technische Universität München
| 5 Jahre |
| Adolf Hoess | M | 62 |
Technische Universität München
| 3 Jahre |
| Dominik Asam | M | 55 |
Technische Universität München
| 1 Jahre |
| Matthias Dörfel | M | 54 |
Technische Universität München
| 1 Jahre |
| Andreas Seidl | M | 61 |
Technische Universität München
| 3 Jahre |
| Ilham Akbar Habibie | M | 61 |
Technische Universität München
| 3 Jahre |
| Daniel von Borries | M | 59 |
Technische Universität München
| 3 Jahre |
| Alexander Helmke | M | - |
Technische Universität München
| 3 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Deutschland | 40 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Benedikte Hatz
- Persönliches Netzwerk
